TY - JOUR
T1 - Complicated disease and response to initial therapy predicts early surgery in paediatric Crohn's disease
T2 - Results from the porto group growth study
AU - on behalf of the Porto Group of ESPGHAN
AU - Levine, Arie
AU - Chanchlani, Neil
AU - Hussey, Seamus
AU - Ziv-Baran, Tomer
AU - Escher, Johanna C.
AU - Amil Dias, Jorge
AU - Veres, Gabor
AU - Koletzko, Sibylle
AU - Turner, Dan
AU - Kolho, Kaija Leena
AU - Paerregaard, Anders
AU - Staiano, Annamaria
AU - Lionetti, Paolo
AU - Nuti, Federica
AU - Sladek, Malgorata
AU - Shaoul, Ron
AU - Lazowska-Prezeorek, Isabella
AU - Martin De Carpi, Javier
AU - Sigall Boneh, Rotem
AU - Pfeffer Gik, Tamar
AU - Cohen-Dolev, Noa
AU - Russell, Richard K.
N1 - Publisher Copyright:
© Copyright 2019 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: [email protected].
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Introduction: The ability to predict risk for poor outcomes in Crohn's disease [CD] would enable early treatment intensification. We aimed to identify children with CD with complications at baseline and throughout the study period who are at risk for surgery 2 years from diagnosis. Methods: Newly diagnosed children with CD were enrolled into a prospective, multicentre inception cohort. Disease characteristics and serological markers were obtained at baseline and week 12 thereafter. Outcome data including disease activity, therapies, complications and need for surgery were collected until the end of 104 weeks. A chi-square automatic interaction detection [CHAID] algorithm was used to develop a prediction model for early surgery. Results: Of 285 children enrolled, 31 [10.9%] required surgery within 2 years. Multivariate analysis identified stricturing disease at baseline (odds ratio [OR] 5.26, 95% confidence interval [CI] 2.02-13.67 [p = 0.001]), and Paediatric Crohn's Disease Activity Index [PCDAI] >10 at week 12 (OR 1.06, 95% CI 1.02-1.10 [p = 0.005]) as key predictors for early surgery. CHAID demonstrated that absence of strictures at diagnosis [7.6%], corticosteroid-free remission at week 12 [4.1%] and early immunomodulator therapy [0.8%] were associated with the lowest risk of surgery, while stricturing disease at diagnosis [27.1%, p < 0.001] or elevated PCDAI at week 12 [16.7%, p = 0.014] had an increased risk of surgery at follow-up. Anti-OmpC status further stratified high-risk patients. Discussion: A risk algorithm using clinical and serological variables at diagnosis and week 12 can categorize patients into high- and low-risk groups from diagnosis.
AB - Introduction: The ability to predict risk for poor outcomes in Crohn's disease [CD] would enable early treatment intensification. We aimed to identify children with CD with complications at baseline and throughout the study period who are at risk for surgery 2 years from diagnosis. Methods: Newly diagnosed children with CD were enrolled into a prospective, multicentre inception cohort. Disease characteristics and serological markers were obtained at baseline and week 12 thereafter. Outcome data including disease activity, therapies, complications and need for surgery were collected until the end of 104 weeks. A chi-square automatic interaction detection [CHAID] algorithm was used to develop a prediction model for early surgery. Results: Of 285 children enrolled, 31 [10.9%] required surgery within 2 years. Multivariate analysis identified stricturing disease at baseline (odds ratio [OR] 5.26, 95% confidence interval [CI] 2.02-13.67 [p = 0.001]), and Paediatric Crohn's Disease Activity Index [PCDAI] >10 at week 12 (OR 1.06, 95% CI 1.02-1.10 [p = 0.005]) as key predictors for early surgery. CHAID demonstrated that absence of strictures at diagnosis [7.6%], corticosteroid-free remission at week 12 [4.1%] and early immunomodulator therapy [0.8%] were associated with the lowest risk of surgery, while stricturing disease at diagnosis [27.1%, p < 0.001] or elevated PCDAI at week 12 [16.7%, p = 0.014] had an increased risk of surgery at follow-up. Anti-OmpC status further stratified high-risk patients. Discussion: A risk algorithm using clinical and serological variables at diagnosis and week 12 can categorize patients into high- and low-risk groups from diagnosis.
KW - Crohn
KW - Crohn's Disease inflammatory bowel disease
KW - child
KW - complications
KW - relapse
KW - serological markers
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85077223888&partnerID=8YFLogxK
U2 - 10.1093/ecco-jcc/jjz111
DO - 10.1093/ecco-jcc/jjz111
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31162532
AN - SCOPUS:85077223888
SN - 1873-9946
VL - 14
SP - 71
EP - 78
JO - Journal of Crohn's and Colitis
JF - Journal of Crohn's and Colitis
IS - 1
ER -